TY - JOUR
T1 - Metabolic syndrome in Xinjiang Kazakhs and construction of a risk prediction model for cardiovascular disease risk
AU - Mao, Lei
AU - He, Jia
AU - Gao, Xiang
AU - Guo, Heng
AU - Wang, Kui
AU - Zhang, Xianghui
AU - Yang, Wenwen
AU - Zhang, Jingyu
AU - Li, Shugang
AU - Hu, Yunhua
AU - Mu, Lati
AU - Yan, Yizhong
AU - Ma, Jiaolong
AU - Ding, Yusong
AU - Zhang, Mei
AU - Liu, Jiaming
AU - Ma, Rulin
AU - Guo, Shuxia
N1 - Publisher Copyright:
© 2018 Mao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2018/9
Y1 - 2018/9
N2 - Background The high prevalence of metabolic syndrome (MetS) and cardiovascular diseases (CVD) is observed among Kazakhs in Xinjiang. Because MetS may significantly predict the occurrence of CVD, the inclusion of CVD-related indicators in metabolic network may improve the predictive ability for a CVD-risk model for Kazakhs in Xinjiang. Methods The study included 2,644 subjects who were followed for 5 years or longer. CVD cases were identified via medical records of the local hospitals from April 2016 to August 2017. Factor analysis was performed in 706 subjects (267 men and 439 women) with MetS to extract CVD-related potential factors from 18 biomarkers tested in a routine health check-up, served as a synthetic predictor (SP). We evaluated the predictive ability of the CVD-risk model using age and SP, logistic regression discrimination for internal validation (n = 384; men = 164, women = 220) and external validation (n = 219; men = 89, women = 130), calculated the probability of CVD for each participant, and receiver operating characteristic curves. Results According to the diagnostic criteria of JIS, the prevalence of MetS in Kazakh was 30.9%. Seven potential factors with a similar pattern were obtained from men and women and comprised the CVD predictors. When predicting CVD in the internal validation, the area under the curve (AUC) were 0.857 (95%CI 0.807–0.898) for men and 0.852 (95%CI 0.809–0.889) for women, respectively. In the external validation, the AUC to predict CVD were 0.914 (95%CI 0.832–0.963) for men and 0.848 (95%CI 0.774–0.905) for women. It is suggested that SP might serve as a useful tool in identifying CVD with in Kazakhs, especially for Kazakhs men. Conclusions Among 7 potential factors were extracted from 18 biomarkrs in Kazakhs with MetS, and SP may be used for CVD risk assessment.
AB - Background The high prevalence of metabolic syndrome (MetS) and cardiovascular diseases (CVD) is observed among Kazakhs in Xinjiang. Because MetS may significantly predict the occurrence of CVD, the inclusion of CVD-related indicators in metabolic network may improve the predictive ability for a CVD-risk model for Kazakhs in Xinjiang. Methods The study included 2,644 subjects who were followed for 5 years or longer. CVD cases were identified via medical records of the local hospitals from April 2016 to August 2017. Factor analysis was performed in 706 subjects (267 men and 439 women) with MetS to extract CVD-related potential factors from 18 biomarkers tested in a routine health check-up, served as a synthetic predictor (SP). We evaluated the predictive ability of the CVD-risk model using age and SP, logistic regression discrimination for internal validation (n = 384; men = 164, women = 220) and external validation (n = 219; men = 89, women = 130), calculated the probability of CVD for each participant, and receiver operating characteristic curves. Results According to the diagnostic criteria of JIS, the prevalence of MetS in Kazakh was 30.9%. Seven potential factors with a similar pattern were obtained from men and women and comprised the CVD predictors. When predicting CVD in the internal validation, the area under the curve (AUC) were 0.857 (95%CI 0.807–0.898) for men and 0.852 (95%CI 0.809–0.889) for women, respectively. In the external validation, the AUC to predict CVD were 0.914 (95%CI 0.832–0.963) for men and 0.848 (95%CI 0.774–0.905) for women. It is suggested that SP might serve as a useful tool in identifying CVD with in Kazakhs, especially for Kazakhs men. Conclusions Among 7 potential factors were extracted from 18 biomarkrs in Kazakhs with MetS, and SP may be used for CVD risk assessment.
UR - http://www.scopus.com/inward/record.url?scp=85053158655&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053158655&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0202665
DO - 10.1371/journal.pone.0202665
M3 - Article
C2 - 30188929
AN - SCOPUS:85053158655
SN - 1932-6203
VL - 13
JO - PloS one
JF - PloS one
IS - 9
M1 - e0202665
ER -